Stockreport

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Beyond Air, Inc.  (XAIR) 
PDF GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmac [Read more]